Nanna Therapeutics

Mighty Therapeutics

This company develops mitochondrial-targeted therapies for patients with rare genetic conditions like Barth syndrome and common age-related diseases.

Pano Therapeautics

This biotechnology company develops small molecule drugs targeting mitochondrial ion channels to treat neurodevelopmental disorders and complex diseases of aging.

Cellergy Therapeutics

This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.

IMEL Biotherapeutics

This company develops mitochondrial replacement cell therapies for patients with genetic mitochondrial disorders and age-related diseases.

MitoRx Therapeutics

MitoRx Therapeutics develops small-molecule therapies restoring mitochondrial health to treat patients with high-risk obesity and degenerative diseases.

Medici Therapeutics

The company develops personalised mRNA cancer vaccines and T cell therapies for patients to treat tumours and combat age-related cellular decline.

NRG Therapeutics

This neuroscience company develops small molecule medicines targeting mitochondrial dysfunction to treat patients with Parkinson's and amyotrophic lateral sclerosis.

Vandria

This biopharmaceutical company develops small molecule mitophagy inducers to treat patients with age-related and chronic diseases, specifically targeting neurodegenerative and muscle disorders.